Roberta Payne, PhD 

This presentation will describe the nature of both otherworldly and self-directed perceptions and concepts experienced by a person with paranoid schizophrenia; and pinpoint the moments in the patient’s cognitive restoration where psychiatric and especially psychological work are crucial.

This presentation will explain the evolving concept of schizophrenia since a paradigm shift in definition has occurred from clinical symptoms or syndromes to biological markers (e.g., genetic; neuroimaging). Second the presentation will focus attention on emerging treatment strategies that improve cognition, mood and negative symptoms, as well as safety and tolerability. Third, the presentation will discuss relative effectiveness of these drugs as well as with the first generation antipsychotics.

This presentation will summarize the relevance of neurocognitive deficits to impairments in work and social functioning and poor rehabilitation outcome in schizophrenia. It will also discuss the relevance of social cognition impairments to schizophrenia and its putative mediating role between neurocognition and community functioning. Moreover, the presenter will compile information on ongoing research efforts that combine interventions that target neurocognitive and social cognitive deficits to improve work performance and work outcome in schizophrenia.

In this presentation, the contemporary uses of the term schizophrenia will be defined. The participant will analyze the etiological evidence that cerebellar anomalies in schizophrenia appear linked to cognitive dysfunction.

This session will summarize the topics discussed throughout the day and engage the audience in analyzing and having further conversation on the issues specific to schizophrenia and human flourishing.